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Introtluction
In the preceeding articles we discussed the relationship between 
_clotting time and
the concdntration 
-of 
clotting factors II, VII, and X when varied simuhutt"oottt'
Clotting time was found to 6e rectilinearly dependent upon the inverse of clotting-
factor concentration (16, 17).
We have indicated ihe'striking similarity between this relationship and the
rectilinear relationship frequently-observed between the inverse of the reaction
velocity and the invJrse of-substrate concentration in simple enzymatic reactions.
The Br"iggs-Ilaldane theory of steady-state enzyme kinetics explains this_relationship
for the#"simple reactions (9). This theory, however, cannot be applied without
modification t-o systems in which coagulation factors interact, because the assumption
that the substraie is present in excess over the gnzytme' which-is one of the basic
assumptions of this th6ory, is very probably not justified in coagulation systems. This
d.oes riot rlisturb the general concept because deletion of this assumption does not
fisturb the rectilinear-relationship between the inverse of reaction velocity and the
inverse of substrat concentratio" 1t+1. Therefore, the possibility must be left open
that the relationship found between coagulation-factor concentration and clottin$
time is dependent up-on a reaction of the Briggs-Haldane t;4pe occurring in the coagula-
tion reaction sequence.
Recognition or tni* possibility compels an inquiry into the mechanism that causes
the intricate reaction i"qo"tr""bf blo^od coagulition to follow such seemingly simple
rules.
In the experiments reported in this article we first of all attempted to establish the
relationship'between thi coneentration of 1!y otg of the factors of the extrinsic
coagulatioi system (factors II, V, VII, and X) and the clotting time in a one-stage
test"specific for that factor. In the discussion we shall elaborate upon the mechanism
that can explain the relationships found'.
prelimiljly experiments indicated that a mod.ification of the cascade scheme (23)
is necessary to explain our findings.
It mighibe poisible that the theory on blood. coagulation proposed by See-gers (26,
27) wouid. give'a ready explanation of our findings. This possibility cannot be taken
into account because the 
-present 
author has not been able to construct a reaction
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scheme of blood coagulation based on Seegers' theory and permitting kinetical treat-
ment, this theory being always explained in diagrams of the flowchart type rather
than in terms of chemical reactions. Although Dr. Seegers was kind enough to enlarge
on his ideas in a personal letter, we did not obtain sufficient information to arrive at
a definite series of reaction formulae such as would be necessary for our purposes.
An interpretation of our data will prove to be impossible without the consideration
of the action of inhibitors or inactivators of the active procoagulants. The introduc-
tion of these substances in our reaction schemes seems justified, because the system
in which we carry out our estimations is not essentially purer than whole plasma is,
and because in plasma many natural inhibitors or inactivators have been recognized
( 1 , 2 , 7 , 8 ,  1 0 ,  1 1 ,  I 3 , 2 L , 2 2 , 2 9 , 3 0 ,  3 1 ) .
Materials antl Methoils
The one-stage measurement's were carried out as already described. The reagents have also boon
described in the preceeding articles (16, 17, 18).
A factor II reagent containing all the necessary procoagulants (i. e. factors I, V, VII, and X)
but lacking Antithrombin III was prepared as follows:
The factor If reagent was diluted twentyfold with twice-distilled water, after which CO2 was
led through the solution for 15 min. The resulting precipitate was collected by centrifugation for
10 min at 12,500 g and dissolved in Michaelis buffer (pH 7.4) Io half the volumo of the original
reagent. The concentration of clotting factors present in this solution was then estimated. Tho
ratio of the concentrat'ion of the factors I, V, VII, and X did not differ significantly from that in
the original material, but the absolute level was higher than that of the original reagent. By further
dilution with Michaelis buffer, the solution was adjusted to the same level of coagulaf,ion factors
as that of the original reagent. In this solution the concentration of Antithrombin III was less
t'}:.at 0.5o/o of that of the original material. Antit'hrombin III was estimated according to l{ensen
(21\.
All experimentai points given in the graphs are the means of at least 12 estimations unless
otherwise indicated.
Experimental Results
All the experiments reported here were so-called one-stage coagulation factor
determinations in the extrinsic system. The objective of these determinations was to
assess the concentration of one factor (F), independent of the other factors; therefore,
a reaction mixture in which the concentration of F would be rate-limiting was required.
This reaction medium had the following composition:
0.1 ml redgent. This reagent is a plasma containing the smallest feasible amount
of F, all other factors being present in relatively high concentration. Tor the sake of
argument, we will assume these other factors to be present in concentrations equal to
the concentration in normal plasma. The minute amount of n'present in the reagent
we will call L.
0.1 ml tissue thrombopld,st'in; providing necessary phospholipid and tissue factor
(human brain thromboplastin according to Owren & Aas).
0.1 ml somple, containing between L to Llo/o F as well other clotting factors.
The reaction is started. by addition of 0.1 ml CaClr2S mM.
In reaction mixtures of the above composition the final concentration of F will
vary between + (L + t)% and I (L + I0)%.The concentrations of the other
clotting factors vary between f (100 1 1) and + (100 + L0)%.The variation in
these concentrations is brought about by the variations in the sample. Because
L<<L00%, the concentration of n' will be much lower than the concentration of the
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other clotting factors. Since the.absolute value of the variation is the same for all
clotting factJrs (at least u'hen filutions of a normal plasma are tested, as is the case
in the experiments described here), this means that the percentage variation in con-
centration is by far the greatest for factor n', and that the concentration of factor n'
is always appreciably smaller than that of the other factors. Consequently, the
yariation in clotting time wilI be essentially a function of the variation in the con-
centration of the added X'and not of that of the other clotting factors. This, by the
way, does not imply that major changes in the final concentration of one of the other
clotting facbors would not influence the clotting time.
That the amount of X' present in the reagent (L) is not negligible can be seen when
buffer is add.ed to the reaction mixture described. above instead of a samplo containing
some concentration of X'. A distinct - although long- clotting timo is then obtained (t6).
For factor II estimations, we have already shown (14, 18) that, with the a pri,ori
a,ssumption that steady-state kinetics can be applied. to the reaction under study, the
magnitude of L can be computed from the slope of a curYe obtained by plotting t.
against (tr - t") : C (C : amount of factor II added with the sample).
The fact that this curve could be demonstrated. to be a straight line, as was predicted
by steady-state kinetics, in combination with the fact that the plot of clotting time
against the inverse of the total concentration (L + C),of factor fI aho was a straigbt
line, was considered as supportive evidence d, posterior'i of the assumptions made
a pri,ori (L8).
We then tried to find out whether the same way of handling data would give useful
results in experimental situations where clotting factors other than factor II were
made rate-limiting. n'igs.1-6 give the results obtained. from experiments in which
each of the factors of the extrinsic system was mad.e rate-limiting. For any of these
factors, clotting time proved to be a linear function of the inverse of the clotting-
Fig.I. The relat'ion oJ Jactor II comoemtration to clotti,ng t'irne. Reaction medium: 0.1 rnl congenital
factor Il-deffcient plasma, 0.1mI normal plasma (diluted 1in 10 to 1in 50), 0.1mI thromboplastin'
and 0.1 ml CaCl, 33 mM. The points roprosent the means of 25 estirrrations.
Tig.2. The relation oJ Jactor II concentral,i,om to clotti,ng ti,me. Reaclion medium: 0.1ml artificial
factor Il-deficient .plasma, 0.1 ml normal plasma (diluted 1 in 10 to 1 in 50), 0.1m1 thrombo-
plastin, and 0.1 ml CaCl, 33 mM. The points ropresont the means of 25 estimations.
t.
Fig. 1.
1O0/lpoaor[] %
F ig .2 .
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Fig.3. The rel'ation oJ Jactor V coneentra?ion to alotti,ng ti,me. F"eaciion modium: 0.1 ml Ba-stearate
absorbednormal plasma, 0.1 ml thromboplastin, 0.1 ml CaClr 2S mM and 0.1 ml sample. Tho points
represont the means of 25 estimations.
Fig..4. The relat'iom oJ Jactor X conoemtrat'ion to clott'ing time. Roaclion medium: 0.1 ml congenital
factor X-deficient plasma, 0.1 ml thromboplastin, 0.1 ml CaCl, 25rn}[ and 0.1 ml samplo. The
points ropresent tho means of 25 estimations.
1oo/lrqctor{%)
Fig.5. The relation oJ Ja'ctor X concentratiom to cl,otting t'ime. Reaction medium: 0.1rnl factor X
def.cien0 plasma from a patient with amyloidosis, 0,1 rnl thromboplastin, 0.1 ml Ca0lr25 mM and
0.1 ml sample. The points represont the means of 10 estirnations,
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Iiig.6. TherelationoJJacW VII ooncentrattionto clottimg ti,m,e.Reac!,iortmediurn: 0.1 ml congenital
raclor yrr-don"i"-r er"T;i:;" ll,XH:il111t?,11'3_r;1 #"T*i3*I 
and 0' 1 mr sample' rhe
factor concentration. Fig.7 shows that it is not possible to apply our procedure_to
the calculation of L in ariexperiment employing a reagent deficient in both factor VII
and factor X. The methodtis also not applicable to data from estimations in the
intrinsic system (i. e. factors VIII, IX, and XII). X'ig.8 shows that the rectilinearity
in a reciprocal piot of a factor II estimation is consistent over the whole range for
which te'stlng is feasible, whereas the rectilinearity in a conventional double loga-
rithmic plot only holds within certain limits.
Eig,1 . Tha aorreatiom plot, obtaineil ui,th a reagent pl,avna d'ef,oi,ant 'im both Jactnrs X an'd' V I I. T}ro
exforimental data do not fit to a straight line in this case, the plot can therefore not bo used to
caldato L. Reaction modium: 0.1mI Seitz filterod bovine oxalatod plasma,0.1ml thrombo-
piastin, 0.1 ml CaCl, 25 mM and 0.1 ml sample. Tho poi-nts represent the means of 25 estirnations.
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I'ig.8, llke reta,tionshi,Tt behreem faotor I I comcemtration and, olotti,ng titne plotteil, 'i,n tuo il,ifferemt uatys.
O-----O logarithrn of clotting time against logarithm of factor II concontration. O------O
clotting tirne against the inverse of factor II concentration. Reaction rnedium: as in X'ig.2. The
points represent.tho moans of 3 estimations. The inverso of C" is given in arbitrary units, so that
t/Cc : 200 whon C" : 10; T1 : clotting timo,
X'ig.9 shows lhat a rectilinear relationship can also be demonstrated when clotting
time is plotted against the inverse of the concentration of the prothrombinaser) gene-
rated in a two-stage test aocording to Biggs (2).
As can be seen from X'ig. 10, the absence of Antithrombin III does not disturb the
recti.linear relationship found in factor II estimations. Fig. 11 shows that in a restricted
concentration range, i. e. in a range where thromboplastin is not present in amounts
high enough to have an inhibitory action, the plot of clott'ing tine against the inverse
of thromboplastin concentration is again a straight line. fn this experiment, haemo-
philic plasma was used as a reagent to prevent the intrinsic coagulation.system from
interfering with the extrinsic system under observation.
I)iscussion
The observation that the relationship between clotting factor concentration and
clotting time follows the rules predicted by the theory of steady-state enzyme kinetics
i{ the differences between the coagulation system and a. simple e\zyrrraiic reaction
are overlooked, can be accepted as an infication that enzJrme kinetics may be applied
to the results of clotting tests. This may constitute a suJfi.cient basis for the design
of the experiments described, but discussion of the results requfues a recognition of
the differencos between the coagulation system and a reaction that can be directlv
described" in terms of steady-state enz5rme kinetics.
1) The namo prothrombinase is used to indicate the actiwity tha0 directly acts upon protlirom-
bin to form thrombin. Tho enzyrnatic nature of this action seoms to be sufffciently proven (15,26)
to justify the suffix-ase in this context,.
a
o
n
g,
I
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Fig.  10.
Fig.$. The relationship betueen prothronrbinose concentiat'ion and, olott'img tim'e. T}r:e prothrombinaso
was obtained as in the first stage of a thromboplastin generation test (1). It was then diluted'
after which the clotting time in the second stage was determinod; clotting time was plotted
against dilution (i. e. the inverse of tho concentration). D : dilution.
X'ig. 10. l[he relation oJ Jactor I I concentration to clotti,ng tim,e in a Ant'ithromb'in L I l-Jree med"ium'.
Reaction medium: as in X'ie.2 but with Antithrombin lfl-free reagent and normal plasma.
1/[Thromuoptostin]
X'ig. 11. lfhe relatdonshi,Tt oJ thromboptlostim concentration to clottdng t't'me. R'eaction medium: 0.2mI
platelet-free factor Vlll-deficient plasma, 0.1mI thromboplastin dilution (diluted 1 in 1 to 1 in
25), and 0.1 ml CaCl, 33 mM.
In the process linking a coagulation-factor concentration in a rate-limiting step
to the final coagulation time in the complete system, three stages can be distinguished:
1. The concentration of the rate-limiting factor gives rise to a teaction velocity in
the rate-limiting step.
- 2. The reaction velocity in the rate-li.miting step causes a certain over-all reaction
velocity, also determined by the concentrations of all procoagulants and anti-
coagulants present in the reaction mixture.
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3. The over-all reaction velocitv causes a certain clotting time.
This implies that the assumption 'r,r'hich served as a w"orking hypothesis, i. e. that
enzyrrne kinetics are applicable to clotting tests, actuallv consists"of three different
assumptions:
a) The reaction velocity in the rate-limiting step bears a relation to the concentra-
tion of the rate-limiting factor that can be describecl by the formulae obtained from
the theory of enzyme kinetics.
b) The initial reaction velocity of a rate-limiting step in the extrinsic pathway is
linearly proportional to the initial over-all reaction velocitv.
c) Clotting time is inversely proportional to the initial over-all reaction velocity.
. 
These three assumptions form the simplest set of assumptions capable of exptaining
the observed phenomena. Theoretically, 'rve cannot disregird the possibility tliat non|
of these assumptions is true. This would not invalidate the rec&nition of the three
stages just mentioned, but it would mean that the relationship in two or more of
these steps would be such that in combination they simulate ihe existence of the
simple relationships expected on the basis of usro*piio.r* a, b, and c. rn other words,
the complexity of one of the steps would be counteracted, by the complexity of one
or more of the others, resulting in a simple over-all picture. It will be shown ihut thi*
must be considered improbable.
We_may now consider the three assumptions separately. Assumption a) cannot be
considered uniikely because there is no reason why enzymatic reactions in blood
coagulation should not behave in the same wav as all other enzl,matic reactions do.
At the moment, we can give no direct probf of assumption c). rn experiments in
yhigh the prothrombinase concentration in mixtures of factor Xr, factori, phospho-
lipid, and Ca ions is assessed irectly bv measuring the velocity of thrombin gJtr"rriiort
from an excess of prothrombin, the inverse of ihe prothrombinasel) con"centration
bears a linear relationship to the inverse of the concentration of any of the constituent
factors (15). when factor X (x'igs.4, 5), factor v (x'ig.3) or phospLohpid (Fig.11) are
made rate-limiting in a one stage test, prothrombinr*e 
"u,.r 
be accefted to"be rate-
limiting. As can be seen from the figures t" bears a linear relationshfo to the inverse
of the rate-limiting factor here. In combination with the data from ref. 15 this can be
accepted as suggestive evidence for the assumption that clotting time is proportional
to the inverse of prothrombinase concentration in experiments in which ihis con-
centration is rate-l imiting; therefore it supports our assumption.
- 
Finally, as long as there is no reasonable objection to assumptions a) and c), ancl
the congruity between theory and practice requires the validity of all three u**orr1p-
tions, we are left with the problem of finding a reasonable basis for assumption b).
This requires the discussion of the various reaction schemes that could p.oriid" *o.L
a basis.
The first reaction scheme of blood coagulation which assigned a well defined place
and role to all known coagulation factors was given in the cascad"e theory of 
-Mac-
farlane (23) or the waterfall sequence of Davie and Ratnoff (6). The basic feature of
this system is the concept of sequential activation. The part of the cascade scheme
relevant to the present work (i. e. the extrinsic pathwayfreads rike this:
tissue factor VIT" X" V-
\ II _____=_+ \iITar \
thrombin
I _____> fibr.in
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The nature of the prothrombin converting entity (prothrombinase) has been a
matter of debate for many years. Its tentative identification with Va in the above
scheme is based on analogy with the other steps. The authors explicitely state that
conclusive evidence for the existence is still lacking (6, 23). The possibility of activated
factor V being the prothrombin converting principle was recognized as early as_1961
by Straub and. Duckert (32); later Breckenridge and Ratnoff provided more evidence
for the correctness of this view (4, 5).
In the meantime from the work of Papahadjopoulos and Flanahan (24), Esnouf
and Jobin (12) and Hemker, Esnouf, Hemker, swart and Macfarlane (15) another
picture of the prothrombinase emerged. According to these investigators prothr-om-
Liou." might consist of a complex of factor Xa and factor V adsorbed onto a phos-
pholipid iicetle surface, factoi Xn being bound via a Ca ion, factor V by a hydro-
pnoni. bond. In that case the reaction scheme of the extrinsic pathway would be:
tissue factor VIIA
vl l --->vl lu, ;X- > Xa.
X" * V * Ca++ f Ph. lip <---+ prothrombinase
prothrombinase
thrombinII
thrombin
I ------+ fibrin
X'irst we will see whether the results of the present communication are compatible
with the original cascade scheme.
The simplest unit in an enzJrlne cascade can be depicted by:
s'-3=*e'  Pr:  Ez s ' - -E'--*P'
When in both reactions the amount of substrate is so large that the reaction velocity
is proportional to the amount of enzyme present, then, as we have shown elsewhere
1201, ihe concentration of P, will rise quadratically with time. The simplification
achieved by assuming an excess of substrate is probable not justified in practice.
Since all m-ore realistic assumptions would introduce more complicated relationships
between P, and time, and since the argument is developed such that even the simple
moclel o*"d h""" would react in a more complicated way than is observed in practice,
the oversimplification does not invalidate the argument. In such a two step cascade
we can make certain decluctions about the relation between clotting time and reaction
velocity. The moment of clotting (ts seconds after initiation of the reaction) can be
established as the moment at which a critical concentration of fibrin monomere is
reached. This critical concentration will be called P". For prothrombin estimations,
Sr : factor II, P1 : thrombin : Ez, Er : prothrombinase, Sz : fibrinogen, and
fl : nUrin monotn"". We expect the fibrin-monomer concentration to rise quadratic-
aliy with time with an acc;leration proportional to the reaction velocity of the
first reaction. If the velocity of the first reaction is vr, then:
P r :  i v r ' t ' ' S o : P " :  * v r  ' t " 2 o r 1 u -  -  V  2 ' P c l v r
This means that the clotting time has to be linearly proportional to the square root
of the inverse of the reaction velocity of the first step. Since we observed a linear
relationship between t" and 1/ (factor II) i. e. we established" that t" : ^ ' t l (factor II)
* bithastofollowthat
2Pslvt : a'.'l (factor II)' + 2ab Ll (factor II) 1 b'z'
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Therefore, the reaction mechanism of factor II conversion would have to be such
that the inverse of the reaction yelocity is a second degree function of the inverse of
the substrate concentration.
Although this remains a possible explanation of the observed data, it must be
considered rather improbable because, as will be shown, simpler explanations are
possible. X'urthermore, reasoning along the same line in a three step cascade mech-
anism, as .would be required to explain the results of the factor V estimations, would
require the velocity of factor V conversion to be a third degree function of factor V
concentration ; factor X conversion velocity would have to bJ a fourth degree function
of factor X concentration etc., which seems to be to remote a possibility to be taken
into account seriously.
It thus appears that our results are not compatible with the original unmodified
cascade scheme. This compels to consider reaction schemes which do account for the
experimental facts observed. The basic feature of these schemes has to be the velocity
of the final "indicator" reaction (the fibrinogen - fibrin conversion) is linearly pro-
portional to the reaction that is rate-limiting in the sequence. Three such schemes vrill
be discussed:
A) The Inacti,aution Mechanism
If the enzyme (E2 : P.)produced bythe first reaction is inactivated in a subsequent
reaction with a velocity that can attain the same magnitude as the velocity of its
formation and that is also dependent upon the amount of the enz;zme (Er) present, a
steady velocity of E, formation will, in the first phase of the reaction, cause a rise of
the concentration of Er. This rise will lead to the acceleration of the breakdown
velocity of Er, and this velocity will consequently increase until it equals the velocity
of formation. It will be clear lhat a constant velocity of the first reaction will cause
a constant level of the first product and hence a constant velocity of the second
reaction. Thus, a steady leuel of E, is the result of a steady uelocity of its formation.
Preliminary mathematical studies indicate that with this mechanism it is not even
necessary for P, to reach its stead.y level for the formation velocity of P, to become
proportional to the formation velocity of Pr.
This postulate has the advantage to assign a place to the physiological anti-
coagulantsknownto bepresent innormalp lasma (L,2,7,8,  10,  11,  13,21,22,29,30,
31 ) .
E,
S1 ---> P1
Pr-inactivator (Er)
inactive product
E 2
S2 -----------> P2
B) The Equi,li,bri,um Mechanism
If P, is a stoichiometric product of E, and S, rather than a product derived from
S, by the action of Er, and if the reaction by which P, is formed is a reversible one,
the condition that P, be broken down at a pace dependent upon its concentration is
fulfilled as it is in the inactivation mechanism, but in an essentially different reaction
seheme:  
T . l  r s  -s l  - r -  ur* l l ,
E2
s, ---+ P,
l
tl
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It seems possible t'hat a combination of the inactivation and the equilibrium mech-
anism plays in the formation of prothrombinase.
According to the modification of the cascade scheme discussed above, prothrom-
binase is a stoichiometric product of factor Xu, factor V, phospholipid and Ca++
(L2, 15, 24). The interaction of these four factors very probably is a reversible one
(L2, 75, 19). It is common knowledge that the prothrombinase activity in plasma
readilY disappears. Probably a plasma factor is responsible for this inactivation (8,
1 1 , 3 1 ) .
The reactions in which prothrombinase takes part according to these publications
can be summarized in the following scheme:
X" * V * Ph. lip + Ca++ =.-2 prothrombin&so -------------) inactive products
hrombin
This is essentially a combination of the theoretical schemes A and B fiscussed aboye,
and thus would be consistent u'ith the experimental facts observed.
ft must be concluded that the modification of the cascade scheme is in better
agreement with our experimental results than the original scheme is.
This modification may provide an explanation for the kinetic behaviour of the
middle part of the reaction sequence but it would leave us with a two step cascade
in the lower reqion viz:
prothrombinase
thrombin
thrombin
fibrin
This would still introduce a non rectilinearify of the plot of clotting time versus the
inverse of prothrombin concentration in a factor II estimation, as well as non-
rectilinearity in a plot of clotting time against the inverse of prothrombinase con-
centration or any of the other plots discussed. All plots however were observed to
be linear.
An equilibrium mechanism obviously fails as an explanation in this case, because
the reaction is known to be irreversible. The inactivation mechanism is feasible
because thrombin is known to react with Antithrombin III to form an inactive
product (21). Removing Antithrombin from a factor II estimation reaction mixture
did not however cause a fisturbance of the observed kinetic behaviour (n'ig. 10).
The inactivation mechanism thus does not yield an explanation either.
A thfud mechanism however can be postulated in which the rate of the second
reaction would equal the rate of the first one, and which thus would explain our
results viz. :
C) The Trans'ient Stote M.echanism
If S, is present in high excoss, every molecule of E, that enters the reaction medium
via the first reaction will immediately be converted into the ErS, complexr) with the
velocity of the formation of Er. The ErS, complex is transformed into the ErP,
complex. If k-1 is small or if the concentration of S, is high, v-, will be negligible
compared to va, andJhe concentration of ErS, wiil build up until v*, equals va r2).
1) With these complexos the enzyme-substrate and enzyme-product, complexes as postulated
in classical enzyrne kinetics are meant (9).
2) Toindicatereactionvelocitiesthosarnesubcriptsa,reusedasfortheindicationoftheconstants.
II
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E 1
s 1 P, (reaction veiocity : vo)
P r : E z
k* ,  k *z  k *g
] i , :  S r<=E2S2eE2p2+rU ,  -  
" ,
Nor,v, if_there is a negligible amount of free Er, v-, will be near zero and va. will
approach v.'r; thus, it will approach vo. This reasoning demonstrates that for some
period in the transient state of the reaction, i. e. in the interval before the steadv-
state situation is reached, it will be possible for the rate of formation of p, to equll
the rate of formation of Er. A concise treatment of the enzyme kinetics involved and
an experimental approach to their application r'vith regard to the fibrinogen-fibrin
conversion are being prepared in our laboratory at the moment. x'rom the above it
is clear that this course of events will be favoured by 1. a great excess of Sr; 2. a large
affinity of E, to Pr; and 3. conditions tending to render v- B yery small. All three theie
conditions seem to be fulfilled in the thrombin-fibrinosen interaction und.er our
circumstances because: a) fibrinogen appears to be present in large excess (2g);
b) thrombin has a strong affinity for fibrin (c. f . the Antithrombin I action of fibrin) ;
and c) as P, is taken away from the reaction medium as an insoluble polymer; the
concentration pf P, will always remain low, and therefore v-, will tend to remain
small. At the moment the transient state mechanism seems to provide a logical
explanation for the behaviour of the last part of the sequence, although it has bj' no
means been proven.
fn the preceeding reaction scheme X, occurs as an entity, whereas the results
mentioned in this article were obtained by variation of the concentration of factor X
and factor VII and therefore by variation of the velocity of X. prod.uction. This too
ca,n be explained by the fact that the formation rate of prothrom6inase rapidly equals
the appearance rate of X*, so that, when factor V and phospholipid are in excess the
level of X, in the reaction medium will rise until the formation rate of prothrombinase
equals the formation rate of Xr.
Preliminary results of a mathematical treatment of this situation show Lhat a
rectilinear relationship will be observed when the observation time of the over-all
reaction (i. e. the clotting time) is of the same order of magnitude as the time neecLed
by the various labile intermediates to reach equilibrium. In other words, the more or
less mechanistic explanation offered above, in which events are explained by the
existence of a steady-state level of labile intermediate (Xs, or prothrombinase), need
not be entirely realistic to give the same experimental results wittr ttre same reaction
scneme.
Preliminary experiments in which these systems were simulated. with an analog
computer have shown that the mechanisms portolut"d above are ind.eed feasible. 
o
It might be questioned if it is necessary to introduce the modification of the cascade
scheme as we did above, because the presence of an inactivator of each of the ac-
tivat_ed,procoagulants would. provide a sufficient basis - at least theoretically - for
our finfings with the aid of hypothesis A only. This however would mean tlat in-
activators of all procoagulants arising during clotting would have to exist. It is well
known that in serum many procoagulants are found in activated form. This possibility
thus seems less realistic than the modification of the cascade scheme^ as eivert
above.
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Conclusion
Whereas the original cascade or waterfall mechanism does not offer an explanation
of the observed kinetics of the extrinsic system, a somewhat different mechanism does.
This mechanism involves a) a stoichiometric-interaction between activated factor X,
factor V, and phospholipid yielding a prothrombinase and b) the existence of an in-
activation mechanism affecting this prothrombinase. In the interaction between
thrombin and fibrinogen ,"transient-state" kinetics are thought to be operative, at,
least until the moment of clotti-ns.
The reaction scheme mieht thus be:
VIIA
x __> x, prothrombinase
inactivator
X" * V -1_ Phospholipid + Ca++ =:-_-+ prothrombin --+ inactive
products
prothrombilase
II
fibrinogen
thrombin
thrombin
fibrin ("transient conditions")
Summary
Observations of the clotting time in one-stage tests in the extrinsic system show,
after suitable correction, that there is a rectilinear relationship between the clotting
time and the inverse of the concentration of the rate-limitins factor. This cannot be
explained by the "c.ascade" or "waterfall" mechanism propo-sed as a schemo for the
interaction of the blood-clotting factors concerned. This relationship can, however, be
explained by a slightly different mechanism.
R6sume
rr'observation d.u temps d.e coagulation i l'aide d'un test en un terrips d.ans le systdme
extrinsdque montte, aprds correction appropri6e, qu'il existeune relation lin6aire entre
le temps de coagulation et I'inverse de la concentration du facteur limitant la vitesse
de la r6action. Cela ne peut s'expliquer par la th6orie dite en "cascade" ou "chute
d'eau" propos6e pour interpr6ter l'interaction des diff6rents facteurs de la coagulation
impliqu6s dans le systdme extrinsdque. cette relation peut, par contre,6tre expliqu6e
par un m6canisme l6gdrement fiff6rent.
Zusammenfassung
Die Bestimmung der Gerinnungszeit mit l[]fe einer Einstufenmethode im rextrin-
sic<-System zeigt, nach-geeigneter Korrektur, eine lineare Reaktion zwischen Gerin-
nungszeit und reziprokem Wert der Konzentration des die Reaktion limitierenden
X'aktors. Diese Tatsache kann durch fie rWasser{all<-Theorie nicht erkld,rt werden, die
fiir die Interpretation der Reaktionen im >extrinsic<-system vorgeschlagen wurde.
Diese Interaktion kann jedoch durch einen d,hnlichen Mechanismus erkld,rt werden.
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Adcl,end,um
Experiments in which plasma congenitally deficient in factor V was used as a reagent gave
essentially tho same result as those with artificiallv factor V deficient plasma described in this
article.
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